Journal Report

Liver Cancer

Download PDF
Journal Information
Journal Title
Liver Cancer
Publisher
S. Karger AG
ISSN
2235-1795
E-ISSN
1664-5553
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
A radio-transcriptome signature for nodule-level prediction of response to atezolizumab plus bevacizumab in hepatocellular carcinoma
Takamitsu Tanaka, Naoto Fujiwara, Takehiro Fujii et al.
2026-10-27
DOI: 10.1159/lic/admag026
2026 International Expert Consensus Recommendations on Image-Guided Ablation for Colorectal Liver Metastases
Rui Cui, Jianming Li, Masatoshi Kudo et al.
2026-10-27
DOI: 10.1159/lic/admag025
EMERALD-3: Is STRIDE-Based TACE Combination Therapy a Breakthrough for Embolization-Eligible Unresectable HCC?
Masatoshi Kudo
2026-10-27
DOI: 10.1159/lic/admag018
Spatiotemporal, Statistical, and Anatomical Considerations for Translating Multi-Omics Cholangiocarcinoma Subtypes into Immunotherapy Biomarkers
Shiyuan Li, Meng Xia
2026-10-12
DOI: 10.1159/lic/admag024
Quavonlimab Coformulated with Pembrolizumab Plus Lenvatinib for Advanced Hepatocellular Carcinoma: Nonrandomized Phase 2 KEYSTEP-004 Trial
Daneng Li, Lorenza Rimassa, Masafumi Ikeda et al.
2026-10-10
DOI: 10.1159/lic/admag013
Dietary cholesterol promotes MASLD-related hepatocellular carcinoma through mitochondrial dysfunction
Xiaoming Zhang, Xingyu Zhou, Xiangtian Yu et al.
2026-10-8
DOI: 10.1159/lic/admag023
Transarterial Chemoembolization Combined with Immunotherapy-Based Systemic Therapy for Hepatocellular Carcinoma: An International ISMIO Expert Consensus Framework
Bin-Yan Zhong, David Madoff, Arndt Vogel et al.
2026-10-7
DOI: 10.1159/lic/admag022
Feasibility of achieving a tumor- and drug-free state through conversion therapy followed by curative hepatectomy for patients with initially unresectable hepatocellular carcinoma (GUIDANCE009)
Da-Long Yang, Yong-Rong Liang, Ze Su et al.
2026-10-7
DOI: 10.1159/lic/admag021
Endothelial Cells Contribute to the Immune-Vascular Milieu Characterizing VETC+ HCC
Barbara Durante, Simone Zanella, Francesco de Napoli et al.
2026-10-1 Pages 1-1
DOI: 10.1159/lic/admag014
Transjugular Intrahepatic Portosystemic Shunt Promotes Hepatocellular Carcinoma Growth in Metabolic Dysfunction Associated Liver Disease
Sofia El Hajji, Stéphanie Lacotte, Andrea Peloso et al.
2026-9-30
DOI: 10.1159/lic/admag017
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 4, 2026 04:23